Living in the Age of COVID-19 Part II
Jennison's Debra Netschert recently spoke with Dr. Larry Brilliant, a world-renowned epidemiologist, about the latest information on COVID-19.
As vaccines become more broadly accessible, the pandemic has entered a new and more optimistic phase in the United States and several other countries. Yet, there remains significant risk in the global system as nations race to immunize their populations in the backdrop of a mutating virus.
Leading epidemiologist Dr. Larry Brilliant speaks with Jennison’s health sciences equity portfolio manager and research analyst Debra Netschert, sharing his insights on the latest developments in the battle against COVID-19 and what lies ahead.
The information in this material has been obtained from sources that Jennison believes to be reliable as of the date presented; however, Jennison cannot guarantee the accuracy of such information, assure its completeness, or warrant such information will not be changed. The information contained herein is current as of the date of issuance (or such earlier date as referenced herein) and is subject to change without notice. Jennison has no obligation to update any or all such information; nor do we make any express or implied warranties or representations as to the completeness or accuracy. Any reproduction of this material, in whole or in part, or the disclosure or redistribution of any of its contents, without the prior written consent of Jennison, is prohibited.
Any projections or forecasts presented herein are subject to change without notice. Actual data will vary and may not be reflected here. No liability whatsoever is accepted for any loss (whether direct, indirect, or consequential) that may arise from any use of the information contained in or derived from this material. Jennison may make investment decisions that are inconsistent with the recommendations or views expressed herein.